Outcomes with drug-coated balloons versus drug-eluting stents for patients with de novo large-vessel coronary artery disease: an updated meta-analysis

Randomized controlled trials have established the role of drug-coated balloon (DCB) for in-stent restenosis and small-vessel coronary artery disease. However, the role of DCB for large-vessel disease (LVD) remains not well established. Electronic databases were searched for studies comparing the clinical outcomes with DCB versus drug-eluting stents (DES) for de novo LVD. The primary outcome was target lesion revascularization (TLR). The secondary endpoints included cardiac mortality, all-cause mortality, myocardial infarction, and major adverse cardiac events (MACE). The angiographic outcomes were late lumen loss (LLL) and acute lumen gain. Summary estimates were pooled using a random-effects model. The pooled analysis showed lower TLR with DCB than DES (2.3% vs. 4.0%; OR = 0.58, 95% CI 0.35–0.98). DCB was associated with lower LLL (MD = − 0.18, 95% CI − 0.30 to − 0.10), whereas DES was associated with greater acute lumen gain (MD = − 0.52, 95% CI − 0.69 to − 0.34). There was no significant difference in MACE, cardiac mortality, all-cause mortality, or myocardial infarction, with pooled ORs (95% CIs) of 0.96 (0.54–1.70), 0.68 (0.37–1.26), 1.05 (0.77–1.43), and 1.05 (0.57–1.92), respectively. Among patients with LVD, DCB might be a reasonable alternative to DES. Additional randomized trials with longer follow-up are needed to confirm these findings.

Authors

Institutions

Publication Details

Journal
European journal of medical research
Published
2026-11-17
DOI
https://doi.org/10.1186/s40001-026-05461-y
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Outcomes with drug-coated balloons versus drug-eluting stents for patients with de novo large-vessel coronary artery disease: an updated meta-analysis

Ahmed Elazab, Islam Y. Elgendy, Ahmed A. Elfeky, Mustafa M. Turkmani et al.
European journal of medical research
Coronary Interventions and Diagnostics
article

Outcomes with drug-coated balloons versus drug-eluting stents for patients with de novo large-vessel coronary artery disease: an updated meta-analysis

Ahmed Elazab, Islam Y. Elgendy, Ahmed A. Elfeky, Mustafa M. Turkmani, Amr Galal, Ameer Awashra, Mohammed A. Elbahloul, Ahmed Wael Hageen, Ahmed Elbataa, Ahmed Mansour, Ammer Alabed, Alaa Abdrabou Abouelmagd, Ahmed I. Elsekhary, Mohamed R. Murad, Sohaila Mansour Abdelsatar, Mohammed Sabri Hassanin, Osama Hasan Emam
article en

Abstract

Randomized controlled trials have established the role of drug-coated balloon (DCB) for in-stent restenosis and small-vessel coronary artery disease. However, the role of DCB for large-vessel disease (LVD) remains not well established. Electronic databases were searched for studies comparing the clinical outcomes with DCB versus drug-eluting stents (DES) for de novo LVD. The primary outcome was target lesion revascularization (TLR). The secondary endpoints included cardiac mortality, all-cause mortality, myocardial infarction, and major adverse cardiac events (MACE). The angiographic outcomes were late lumen loss (LLL) and acute lumen gain. Summary estimates were pooled using a random-effects model. The pooled analysis showed lower TLR with DCB than DES (2.3% vs. 4.0%; OR = 0.58, 95% CI 0.35–0.98). DCB was associated with lower LLL (MD = − 0.18, 95% CI − 0.30 to − 0.10), whereas DES was associated with greater acute lumen gain (MD = − 0.52, 95% CI − 0.69 to − 0.34). There was no significant difference in MACE, cardiac mortality, all-cause mortality, or myocardial infarction, with pooled ORs (95% CIs) of 0.96 (0.54–1.70), 0.68 (0.37–1.26), 1.05 (0.77–1.43), and 1.05 (0.57–1.92), respectively. Among patients with LVD, DCB might be a reasonable alternative to DES. Additional randomized trials with longer follow-up are needed to confirm these findings.

European journal of medical research
Beni-Suef University (EG), Kafrelsheikh University (EG), University of Kentucky (US), Cairo University (EG), An-Najah National University (PS), Al-Azhar University (EG), South Valley University (EG), Tanta University (EG), Michigan State University (US), Damascus University (SY), University of Toledo (US)
Coronary Interventions and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon